Literature DB >> 23572425

Voxel-based analysis of amyloid-burden measured with [(11)C]PiB PET in a double transgenic mouse model of Alzheimer's disease.

Boris von Reutern1, Barbara Grünecker, Behrooz H Yousefi, Gjermund Henriksen, Michael Czisch, Alexander Drzezga.   

Abstract

PURPOSE: The purpose of this study is to validate the feasibility of a voxel-based analysis of in vivo amyloid-β positron emission tomography (PET) imaging studies in transgenic mouse models of Alzheimer's disease. PROCEDURES: We performed [(11)C]PiB PET imaging in 20 APP/PS1 mice and 16 age-matched controls, and histologically determined the individual amyloid-β plaque load. Using SPM software, we performed a voxel-based group comparison plus a regression analysis between PiB retention and actual plaque load, both thresholded at p FWE < 0.05. In addition, we carried out an individual ROI analysis in every animal.
RESULTS: The automated voxel-based group comparison allowed us to identify voxels with significantly increased PiB retention in the cortical and hippocampal regions in transgenic animals compared to controls. The voxel-based regression analysis revealed a significant association between this signal increase and the actual cerebral plaque load. The validity of these results was corroborated by the individual ROI-based analysis.
CONCLUSIONS: Voxel-based analysis of in vivo amyloid-β PET imaging studies in mouse models of Alzheimer's disease is feasible and allows studying the PiB retention patterns in whole brain maps. Furthermore, the selected approach in our study also allowed us to establish a quantitative relation between tracer retention and actual plaque pathology in the brain in a voxel-wise manner.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23572425     DOI: 10.1007/s11307-013-0625-z

Source DB:  PubMed          Journal:  Mol Imaging Biol        ISSN: 1536-1632            Impact factor:   3.488


  35 in total

1.  Microglia, amyloid, and cognition in Alzheimer's disease: An [11C](R)PK11195-PET and [11C]PIB-PET study.

Authors:  Paul Edison; Hilary A Archer; Alexander Gerhard; Rainer Hinz; Nicola Pavese; Federico E Turkheimer; Alexander Hammers; Yen Fong Tai; Nick Fox; Angus Kennedy; Martin Rossor; David J Brooks
Journal:  Neurobiol Dis       Date:  2008-08-15       Impact factor: 5.996

2.  Detection by voxel-wise statistical analysis of significant changes in regional cerebral glucose uptake in an APP/PS1 transgenic mouse model of Alzheimer's disease.

Authors:  Albertine Dubois; Anne-Sophie Hérard; Benoît Delatour; Philippe Hantraye; Gilles Bonvento; Marc Dhenain; Thierry Delzescaux
Journal:  Neuroimage       Date:  2010-03-04       Impact factor: 6.556

3.  PET imaging of brain with the beta-amyloid probe, [11C]6-OH-BTA-1, in a transgenic mouse model of Alzheimer's disease.

Authors:  Hiroshi Toyama; Daniel Ye; Masanori Ichise; Jeih-San Liow; Lisheng Cai; David Jacobowitz; John L Musachio; Jinsoo Hong; Mathew Crescenzo; Dnyanesh Tipre; Jian-Qiang Lu; Sami Zoghbi; Douglass C Vines; Jurgen Seidel; Kazuhiro Katada; Michael V Green; Victor W Pike; Robert M Cohen; Robert B Innis
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-03-25       Impact factor: 9.236

4.  Localization of neurofibrillary tangles and beta-amyloid plaques in the brains of living patients with Alzheimer disease.

Authors:  Kooresh Shoghi-Jadid; Gary W Small; Eric D Agdeppa; Vladimir Kepe; Linda M Ercoli; Prabha Siddarth; Stephen Read; Nagichettiar Satyamurthy; Andrej Petric; Sung-Cheng Huang; Jorge R Barrio
Journal:  Am J Geriatr Psychiatry       Date:  2002 Jan-Feb       Impact factor: 4.105

5.  The effect of anaesthesia on [(18)F]MK-9470 binding to the type 1 cannabinoid receptor in the rat brain.

Authors:  Cindy Casteels; Guy Bormans; Koen Van Laere
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-02-25       Impact factor: 9.236

6.  Longitudinal, quantitative assessment of amyloid, neuroinflammation, and anti-amyloid treatment in a living mouse model of Alzheimer's disease enabled by positron emission tomography.

Authors:  Jun Maeda; Bin Ji; Toshiaki Irie; Takami Tomiyama; Masahiro Maruyama; Takashi Okauchi; Matthias Staufenbiel; Nobuhisa Iwata; Maiko Ono; Takaomi C Saido; Kazutoshi Suzuki; Hiroshi Mori; Makoto Higuchi; Tetsuya Suhara
Journal:  J Neurosci       Date:  2007-10-10       Impact factor: 6.167

7.  Voxel-based analysis of 11C-PIB scans for diagnosing Alzheimer's disease.

Authors:  Arthur Mikhno; Davangere Devanand; Gregory Pelton; Katrina Cuasay; Roger Gunn; Neil Upton; Robert Y Lai; Vincenzo Libri; J John Mann; Ramin V Parsey
Journal:  J Nucl Med       Date:  2008-07-16       Impact factor: 10.057

8.  Follow-up of [11C]PIB uptake and brain volume in patients with Alzheimer disease and controls.

Authors:  N M Scheinin; S Aalto; J Koikkalainen; J Lötjönen; M Karrasch; N Kemppainen; M Viitanen; K Någren; S Helin; M Scheinin; J O Rinne
Journal:  Neurology       Date:  2009-09-02       Impact factor: 9.910

9.  In-vivo imaging of Alzheimer disease beta-amyloid with [11C]SB-13 PET.

Authors:  Nicolaas P L G Verhoeff; Alan A Wilson; Shinichiro Takeshita; Liat Trop; Doug Hussey; Kernjit Singh; Hank F Kung; Mei-Ping Kung; Sylvain Houle
Journal:  Am J Geriatr Psychiatry       Date:  2004 Nov-Dec       Impact factor: 4.105

10.  Voxel-based morphometry in the R6/2 transgenic mouse reveals differences between genotypes not seen with manual 2D morphometry.

Authors:  S J Sawiak; N I Wood; G B Williams; A J Morton; T A Carpenter
Journal:  Neurobiol Dis       Date:  2008-10-01       Impact factor: 5.996

View more
  9 in total

1.  A longitudinal multimodal in vivo molecular imaging study of the 3xTg-AD mouse model shows progressive early hippocampal and taurine loss.

Authors:  Samuel Chiquita; Mário Ribeiro; João Castelhano; Francisco Oliveira; José Sereno; Marta Batista; Antero Abrunhosa; Ana C Rodrigues-Neves; Rafael Carecho; Filipa Baptista; Catarina Gomes; Paula I Moreira; António F Ambrósio; Miguel Castelo-Branco
Journal:  Hum Mol Genet       Date:  2019-07-01       Impact factor: 6.150

2.  Longitudinal PET-MRI reveals β-amyloid deposition and rCBF dynamics and connects vascular amyloidosis to quantitative loss of perfusion.

Authors:  Florian C Maier; Hans F Wehrl; Andreas M Schmid; Julia G Mannheim; Stefan Wiehr; Chommanad Lerdkrai; Carsten Calaminus; Anke Stahlschmidt; Lan Ye; Michael Burnet; Detlef Stiller; Osama Sabri; Gerald Reischl; Mathias Staufenbiel; Olga Garaschuk; Mathias Jucker; Bernd J Pichler
Journal:  Nat Med       Date:  2014-11-10       Impact factor: 53.440

3.  Preclinical Comparison of the Amyloid-β Radioligands [(11)C]Pittsburgh compound B and [(18)F]florbetaben in Aged APPPS1-21 and BRI1-42 Mouse Models of Cerebral Amyloidosis.

Authors:  Ann-Marie Waldron; Jeroen Verhaeghe; Leonie wyffels; Mark Schmidt; Xavier Langlois; Annemie Van Der Linden; Sigrid Stroobants; Steven Staelens
Journal:  Mol Imaging Biol       Date:  2015-10       Impact factor: 3.488

4.  Alzheimer's disease biomarkers in animal models: closing the translational gap.

Authors:  Jonathan J Sabbagh; Jefferson W Kinney; Jeffrey L Cummings
Journal:  Am J Neurodegener Dis       Date:  2013-06-21

5.  Cross-sectional comparison of small animal [18F]-florbetaben amyloid-PET between transgenic AD mouse models.

Authors:  Matthias Brendel; Anna Jaworska; Eric Grießinger; Christina Rötzer; Steffen Burgold; Franz-Josef Gildehaus; Janette Carlsen; Paul Cumming; Karlheinz Baumann; Christian Haass; Harald Steiner; Peter Bartenstein; Jochen Herms; Axel Rominger
Journal:  PLoS One       Date:  2015-02-23       Impact factor: 3.240

6.  Early Detection of Aβ Deposition in the 5xFAD Mouse by Amyloid PET.

Authors:  Se Jong Oh; Hae-June Lee; Kyung Jun Kang; Sang Jin Han; Yong Jin Lee; Kyo Chul Lee; Sang Moo Lim; Dae Yoon Chi; Kyeong Min Kim; Ji-Ae Park; Jae Yong Choi
Journal:  Contrast Media Mol Imaging       Date:  2018-02-28       Impact factor: 3.161

7.  FIBT versus florbetaben and PiB: a preclinical comparison study with amyloid-PET in transgenic mice.

Authors:  Behrooz H Yousefi; Boris von Reutern; Daniela Scherübl; André Manook; Markus Schwaiger; Timo Grimmer; Gjermund Henriksen; Stefan Förster; Alexander Drzezga; Hans-Jürgen Wester
Journal:  EJNMMI Res       Date:  2015-03-28       Impact factor: 3.138

8.  Magnetic resonance imaging for monitoring therapeutic response in a transgenic mouse model of Alzheimer's disease using voxel-based analysis of amyloid plaques.

Authors:  Jae-Hun Kim; Tae Lin Ha; Geun Ho Im; Jehoon Yang; Sang Won Seo; Julius Juhyun Chung; Sun Young Chae; In Su Lee; Jung Hee Lee
Journal:  Neuroreport       Date:  2014-03-05       Impact factor: 1.837

9.  Automated Spatial Brain Normalization and Hindbrain White Matter Reference Tissue Give Improved [(18)F]-Florbetaben PET Quantitation in Alzheimer's Model Mice.

Authors:  Felix Overhoff; Matthias Brendel; Anna Jaworska; Viktoria Korzhova; Andreas Delker; Federico Probst; Carola Focke; Franz-Josef Gildehaus; Janette Carlsen; Karlheinz Baumann; Christian Haass; Peter Bartenstein; Jochen Herms; Axel Rominger
Journal:  Front Neurosci       Date:  2016-02-29       Impact factor: 4.677

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.